Updates T-DXd (gastric) & SC Dara (AL Amyloidosis)
Jan 21, 2021
18:23
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Discussing recent FDA approvals for expanded indications for trastuzumab-deruxtecan for gastric cancer (based on DESTINY-Gastric01) and SC daratumumab for AL amyloidosis.
DESTINY-Gastric01: https://www.nejm.org/doi/full/10.1056/NEJMoa2004413
